Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
8,732,023
-
Share change
-
-419,145
-
Total reported value
-
$9,079,704
-
Put/Call ratio
-
94%
-
Price per share
-
$1.04
-
Number of holders
-
48
-
Value change
-
-$467,329
-
Number of buys
-
14
-
Number of sells
-
23
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q1 2023
As of 31 Mar 2023 Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,732,023 shares of stock of the company.
Largest 10 holders included Carmignac Gestion, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, FIRST MANHATTAN CO. LLC., JOHNSON & JOHNSON, and Assenagon Asset Management S.A..
This table shows 48 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.